Calumet (CLMT) Cash & Equivalents (2022 - 2026)

Calumet (CLMT) has 5 years of Cash & Equivalents data on file, last reported at $138.6 million in Q1 2026.

• Quarterly Cash & Equivalents rose 12.32% year-over-year to $138.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $138.6 million (up 12.32% YoY) and the FY2025 annual result came in at $125.1 million, up 228.35% from the prior year.
• Cash & Equivalents grew to $138.6 million in Q1 2026 per CLMT's latest filing, from $125.1 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $138.6 million in Q1 2026 and bottomed at $7.0 million in Q2 2024.
• The 5-year median for Cash & Equivalents is $38.1 million (2024), against an average of $61.2 million.
• The widest annual swing landed in 2024, when Cash & Equivalents tumbled 83.57%; it then surged 1480.0% in 2025.
• Tracing CLMT's Cash & Equivalents over 5 years: stood at $35.2 million in 2022, then slumped by 77.56% to $7.9 million in 2023, then surged by 382.28% to $38.1 million in 2024, then soared by 228.35% to $125.1 million in 2025, then gained by 10.79% to $138.6 million in 2026.
• Per Business Quant, the three latest CLMT Cash & Equivalents figures stand at $138.6 million (Q1 2026), $125.1 million (Q4 2025), and $94.6 million (Q3 2025).

Peer Comparison